Geriatric patient outcomes in a multidisciplinary central nervous system community hospital clinic for radiation oncology and neurosurgery (RADIANS).


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
06 2022
Historique:
received: 08 06 2021
revised: 01 12 2021
accepted: 22 12 2021
pubmed: 2 1 2022
medline: 23 6 2022
entrez: 1 1 2022
Statut: ppublish

Résumé

Management of older adult patients with central nervous system (CNS) cancers requires a patient-centric, multidisciplinary approach. Assessment of neurosurgical and radiation treatment outcomes can assist in establishing guidelines for this patient population. We previously reported on the RADIANS clinic, a novel community hospital-based multidisciplinary clinic (MDC) for CNS cancer care, providing simultaneous radiation oncology and neurosurgery evaluation in a same-day, single-setting clinic. We now provide a focused analysis of our older adult patient population and recommendations for triage and standardization of care. Consecutive older adult patients (age ≥ 65) evaluated at the RADIANS clinic for CNS disease were identified and retrospectively reviewed. Observed 30-day neurosurgical outcomes were compared to predicted outcomes determined by the American College of Physicians NSQIP Surgical Risk Calculator. One-sample binomial exact tests were used to evaluate binary outcome measures. A two-sample t-test was used to evaluate the length of hospital stay. Brier Scores were calculated to assess the deviation between predicted probabilities and observed outcomes for binary outcome measures. Overall survival at 90 days was reported. Fifty-six older adult patients with malignant (42/56) and benign (14/56) CNS disease were evaluated. Mean distance traveled for multidisciplinary evaluation at the RADIANS clinic was 43.4 miles. There was no incidence of radiation-induced toxicity. Mean length of hospital stay for RADIANS patients was significantly shorter by about 1.5 to 3.5 days (95% CI). There was no statistically significant difference for other outcome measures, however, Brier Scores demonstrated that NSQIP was not a good predictive tool for any or serious complications, UTI, venous thromboembolism, return to OR, readmission, or death in our cohort. Local tumor control rate and progression-free survival at 90 days were 97.4% and 76.9%, respectively. This is the first report of CNS disease outcomes in older adult patients evaluated by radiation oncology and neurosurgery at a community hospital-based MDC. We observed minimal adverse radiation outcomes and high tumor control in our cohort. Findings show significantly shorter postoperative hospital stay for patients evaluated and managed at the RADIANS clinic.

Identifiants

pubmed: 34972643
pii: S1879-4068(21)00662-7
doi: 10.1016/j.jgo.2021.12.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

648-653

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Rohi Gheewala (R)

School of Medicine, Oregon Health and Science University, USA.

Wencesley A Paez (WA)

Department of Radiation Medicine, Oregon Health and Science University, USA. Electronic address: paezw@ohsu.edu.

William Stadtlander (W)

Department of Radiation Medicine, Oregon Health and Science University, USA.

Brandon Lucke-Wold (B)

Department of Neurological Surgery, University of Florida, USA.

Jerry J Jaboin (JJ)

Department of Radiation Medicine, Oregon Health and Science University, USA.

Charles R Thomas (CR)

Department of Radiation Medicine, Oregon Health and Science University, USA; Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College, USA.

Timur Mitin (T)

Department of Radiation Medicine, Oregon Health and Science University, USA.

Jeremy N Ciporen (JN)

Department of Neurological Surgery, Oregon Health and Science University, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH